Announced Sat, 27 Sept · 14:43 IST

Par Drugs And Chemicals Limited has informed the Exchange about Proceeding of AGM

Board & Shareholder Meetings View source PDF

PAR · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Par Drugs and Chemicals held its 26th AGM on 27th September 2025 in Vadodara, chaired by CMD Mr. Falgun V. Savani. The meeting ran from 11:00 AM to 12:20 PM with 42 shareholders present out of 14,498 on the cut-off date. In his speech, the Chairman shared FY25 financial highlights: total revenue rose to ₹10,312.38 lakh from ₹9,588.27 lakh in FY24, but profit before tax slipped to ₹1,792.29 lakh (vs ₹1,951.66 lakh) and net profit declined to ₹1,335.79 lakh (vs ₹1,450.10 lakh), citing higher material costs and other expenses. The CEO also presented a detailed review of the balance sheet, profit & loss, and cash flow statements from the annual report. All resolutions tabled in the AGM notice were put to vote via remote e-voting and ballot paper, with results to be declared later. No qualifications or adverse remarks were noted in the statutory auditors' report.

Likely market impact

Routine procedural filing with no major surprises. The slight dip in profits despite higher revenue may concern investors, but overall the company continues to grow its top line. Voting results on the resolutions are awaited and could be the next stock-moving event.